CREG1 Attenuates Osteoarthritis Progression by Suppressing Chondrocyte Pyroptosis Through the PINK1/Parkin‐Mediated Mitophagy Pathway
Biotechnology Journal · 2026
DOI: 10.1002/biot.70196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Xianming Fei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Ch…. Hauptthemen laut MEDLINE: Pyroptosis, Mitophagy, Chondrocytes, Protein Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China.
Abstract (Originalsprache)
Background
Osteoarthritis (OA) is a progressive degenerative disorder driven by complex pathogenic mechanisms. Increasing evidence indicates that NLRP3 inflammasome–mediated chondrocyte pyroptosis contributes critically to OA progression. Cellular repressor of E1A‐stimulated gene 1 (CREG1), a secreted glycoprotein involved in cellular homeostasis and lysosomal function, has not been well characterized in OA. This study aimed to investigate the role of CREG1 in OA and its underlying molecular mechanisms.
Methods
Human knee OA cartilage samples were analyzed to evaluate the association between CREG1 expression and chondrocyte pyroptosis. An LPS/ATP‐induced in vitro pyroptosis model was used to assess the effects of CREG1 on chondrocyte apoptosis, extracellular matrix (ECM) degradation, NLRP3 inflammasome activation, and PINK1/Parkin‐dependent mitophagy. Cyclosporin A (CsA) was applied to inhibit mitophagy.
Results
CREG1 expression was significantly reduced in OA cartilage and negatively correlated with chondrocyte pyroptosis. CREG1 silencing aggravated apoptosis and ECM degradation, promoted NLRP3 inflammasome activation, impaired mitophagy, and disrupted mitochondrial function. Conversely, CREG1 overexpression restored PINK1/Parkin‐mediated mitophagy, improved mitochondrial homeostasis, and suppressed NLRP3 inflammasome activation. These effects were abolished by CsA treatment.
Conclusions
CREG1 protects against OA progression by suppressing NLRP3 inflammasome–driven chondrocyte pyroptosis through activation of PINK1/Parkin‐dependent mitophagy, highlighting CREG1 as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- Department of Orthopaedics, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Shandong Qingdao, China.
- Department of Spinal surgery, Zhongda Hospital, College of Medicine, Southeast University, Nanjing, Jiangsu, China.
ORCID-Profile: Wei Xu
Förderung
- Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
Zitieren
APA
Fei, X., Liu, S., Song, G., Dong, S., Song, Z., & Xu, W. (2026). CREG1 Attenuates Osteoarthritis Progression by Suppressing Chondrocyte Pyroptosis Through the PINK1/Parkin‐Mediated Mitophagy Pathway. Biotechnology Journal. https://doi.org/10.1002/biot.70196
Vancouver
Fei X, Liu S, Song G, Dong S, Song Z, Xu W. CREG1 Attenuates Osteoarthritis Progression by Suppressing Chondrocyte Pyroptosis Through the PINK1/Parkin‐Mediated Mitophagy Pathway. Biotechnology Journal. 2026. doi:10.1002/biot.70196
BibTeX
@article{Fei2026,
author = {Fei, Xianming and Liu, Shuanggong and Song, Guangxu and Dong, Shuhang and Song, Ziyi and Xu, Wei},
title = {CREG1 Attenuates Osteoarthritis Progression by Suppressing Chondrocyte Pyroptosis Through the PINK1/Parkin‐Mediated Mitophagy Pathway},
journal = {Biotechnology Journal},
year = {2026},
doi = {10.1002/biot.70196}
}
EUVIMED